Orexin-a activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area

被引:101
作者
Uramura, K
Funahashi, H
Muroya, S
Shioda, S
Takigawa, M
Yada, T [1 ]
机构
[1] Jichi Med Sch, Dept Physiol, Kawachi, Tochigi 3290498, Japan
[2] Kagoshima Univ, Fac Med, Dept Neuropsychiat, Kagoshima 8908520, Japan
[3] Showa Univ, Sch Med, Dept Anat, Tokyo 1428555, Japan
[4] Natl Inst Physiol Sci, Lab Intracellular Metab, Okazaki, Aichi 4448585, Japan
关键词
Ca2+ channel; cytosolic Ca2+ concentration; dopamine neuron; orexin; phospholipase C; protein kinase C; ventral tegmental area; VTA;
D O I
10.1097/00001756-200107030-00024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The orexin-orexin receptor system has been implicated in the regulation of wakefulness/sleep states. Behavioral and psychostimulant effects of orexins have also been shown. Mesolimbic dopamine neurons in the ventral tegmental area (VTA) are implicated in the regulation of reward and wakefulness/sleep, In the present study, we examined the effect of orexin-A on cytosolic [Ca2+](i) concentration ([Ca2+]) in the isolated rat VTA dopamine neurons. Orexin-A (10(-12)-10(-8)M) concentration dependently increased [Ca2+](i) in dopamine-containing neurons. The [Ca2+](i) responses to orexin-A were inhibited under Ca2+-free conditions and by blockers of voltage-gated Land N-type [Ca2+](i) channels, nitrendipine and omega -conotoxin, respectively. The [Ca2+](i) responses were also abolished by a phosphatidylcholine-specific phospholipase C inhibitor, D609, and a protein kinase C (PKC) inhibitor, calphostin C. A PKC activator, TPA, mimicked orexin-A in increasing [Ca2+](i). These results indicate that orexin-A increases [Ca2+](i) in VTA dopamine neurons via phosphatidylcholine-specific PLC- and PKC-mediated activation of L- and N-type Ca2+ channels. This effect may serve as the mechanism by which orexin regulates wakefulness/sleep states and exerts its behavioral and psychostimulant effects. NeuroReport 12:1885-1889 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:1885 / 1889
页数:5
相关论文
共 22 条
[1]   INHIBITION BY PERTUSSIS TOXIN OF THE SOPORIFIC EFFECTS INDUCED BY STIMULATION OF DOPAMINE-D2 AUTORECEPTORS IN THE VENTRAL TEGMENTAL AREA IN RATS [J].
BAGETTA, G ;
DESARRO, GB ;
PRIOLO, E ;
MARRA, R ;
NISTICO, G .
NEUROPHARMACOLOGY, 1989, 28 (09) :941-947
[2]   VENTRAL TEGMENTAL AREA - SITE THROUGH WHICH DOPAMINE D-2 RECEPTOR AGONISTS EVOKE BEHAVIORAL AND ELECTROCORTICAL SLEEP IN RATS [J].
BAGETTA, G ;
DESARRO, G ;
PRIOLO, E ;
NISTICO, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (03) :860-866
[3]   DOPAMINE FUNCTIONS IN APPETITIVE AND DEFENSIVE BEHAVIORS [J].
BLACKBURN, JR ;
PFAUS, JG ;
PHILLIPS, AG .
PROGRESS IN NEUROBIOLOGY, 1992, 39 (03) :247-279
[4]   THE EFFECTS OF L-DOPA ON EXCESSIVE DAYTIME SLEEPINESS IN NARCOLEPSY [J].
BOIVIN, DB ;
MONTPLAISIR, J .
NEUROLOGY, 1991, 41 (08) :1267-1269
[5]   LONG-TERM INFLUENCE OF D-AMPHETAMINE ON MESOLIMBIC BRAIN-STIMULATION REWARD - COMPARISON TO CHRONIC HALOPERIDOL AND NALOXONE EFFECTS [J].
BOROWSKI, TB ;
KOKKINIDIS, L .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (01) :1-15
[6]   Narcolepsy in orexin knockout mice:: Molecular genetics of sleep regulation [J].
Chemelli, RM ;
Willie, JT ;
Sinton, CM ;
Elmquist, JK ;
Scammell, T ;
Lee, C ;
Richardson, JA ;
Williams, SC ;
Xiong, YM ;
Kisanuki, Y ;
Fitch, TE ;
Nakazato, M ;
Hammer, RE ;
Saper, CB ;
Yanagisawa, M .
CELL, 1999, 98 (04) :437-451
[7]   ELECTRICAL-STIMULATION OF REWARD SITES IN THE VENTRAL TEGMENTAL AREA INCREASES DOPAMINE TRANSMISSION IN THE NUCLEUS-ACCUMBENS OF THE RAT [J].
FIORINO, DF ;
COURY, A ;
FIBIGER, HC ;
PHILLIPS, AG .
BEHAVIOURAL BRAIN RESEARCH, 1993, 55 (02) :131-141
[8]   VOLTAGE-GATED CALCIUM CURRENTS IN THE MAGNOCELLULAR NEUROSECRETORY-CELLS OF THE RAT SUPRAOPTIC NUCLEUS [J].
FISHER, TE ;
BOURQUE, CW .
JOURNAL OF PHYSIOLOGY-LONDON, 1995, 486 (03) :571-580
[9]   The effect of leptin on feeding-regulating neurons in the rat hypothalamus [J].
Funahashi, H ;
Yada, T ;
Muroya, S ;
Takigawa, M ;
Ryushi, T ;
Horie, S ;
Nakai, Y ;
Shioda, S .
NEUROSCIENCE LETTERS, 1999, 264 (1-3) :117-120
[10]  
KALIVAS PW, 1988, J PHARMACOL EXP THER, V245, P1095